Skip to content

Insider · CIK 0001976326

Haeberlein Samantha L. Budd

director

Files at VIGL (Vigil Neuroscience, Inc.). First filing Dec 19, 2024, latest Dec 19, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$21k bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
31Weak
VIGLbuy 2
Vigil Neuroscience, Inc.
$21k
12,000 shares
--

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 5, 2025VIGL
Vigil Neuroscience, Inc.
DDisposition to issuer
Common Stock
-5,000--0Aug 5, 2025
Aug 5, 2025VIGL
Vigil Neuroscience, Inc.
DDisposition to issuer
Common Stock
-12,000--0Aug 5, 2025
Aug 5, 2025VIGL
Vigil Neuroscience, Inc.
DDisposition to issuer
Stock Option Award (Right to Buy)derivative
-18,068--0Aug 5, 2025
Aug 5, 2025VIGL
Vigil Neuroscience, Inc.
DDisposition to issuer
Stock Option Award (Right to Buy)derivative
-13,928--0Aug 5, 2025
Aug 5, 2025VIGL
Vigil Neuroscience, Inc.
DDisposition to issuer
Stock Option Award (Right to Buy)derivative
-30,694--0Aug 5, 2025
May 22, 2025VIGL
Vigil Neuroscience, Inc.
AGrant or award
Common Stock
+5,000$0.00$017,000May 23, 2025
Dec 19, 2024VIGL
Vigil Neuroscience, Inc.
POpen-market purchase
Common Stock
+12,000$1.71$21k12,000Dec 19, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Haeberlein Samantha L. Budd: insider trades and track record | InsiderTell